0001127602-24-013718.txt : 20240501
0001127602-24-013718.hdr.sgml : 20240501
20240501114742
ACCESSION NUMBER: 0001127602-24-013718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240430
FILED AS OF DATE: 20240501
DATE AS OF CHANGE: 20240501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarr Mark J
CENTRAL INDEX KEY: 0001304057
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10315
FILM NUMBER: 24901425
MAIL ADDRESS:
STREET 1: C/O ENCOMPASS HEALTH CORPORATION
STREET 2: 9001 LIBERTY PARKWAY
CITY: BIRMINGHAM
STATE: AL
ZIP: 35242
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Encompass Health Corp
CENTRAL INDEX KEY: 0000785161
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 630860407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9001 LIBERTY PARKWAY
CITY: BIRMINGHAM
STATE: AL
ZIP: 35242
BUSINESS PHONE: 205-967-7116
MAIL ADDRESS:
STREET 1: 9001 LIBERTY PARKWAY
CITY: BIRMINGHAM
STATE: AL
ZIP: 35242
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHSOUTH CORP
DATE OF NAME CHANGE: 19950113
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-04-30
0000785161
Encompass Health Corp
EHC
0001304057
Tarr Mark J
2537 WATKINS ROAD
MOUNTAIN BROOK
AL
35223
1
1
President & CEO
0
Encompass Health Common Stock
2024-04-30
4
M
0
19460
35.83
A
573558
D
Encompass Health Common Stock
2024-04-30
4
M
0
25516
29.06
A
599074
D
Encompass Health Common Stock
2024-04-30
4
S
0
44976
83.27
D
554098
D
Non-qualified Stock Option (Right to Buy)
35.83
2024-04-30
4
M
0
19460
0
D
2016-03-03
2025-03-03
Encompass Health Common Stock
19460
0
D
Non-qualified Stock Option (Right to Buy)
29.06
2024-04-30
4
M
0
25516
0
D
2017-02-26
2026-02-26
Encompass Health Common Stock
25516
0
D
This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.
/s/ Patrick Darby, attorney-in-fact for Mark J. Tarr
2024-05-01